A Nationwide Study on the Incidence of Breast Cancer in Korean Women with Osteoporosis Receiving Raloxifene Treatment

PURPOSE: Raloxifene is a selective estrogen receptor modulator (SERM), and raloxifene treatment for osteoporosis is reimbursable under the Korean National Health Insurance. Evidence suggests that SERMs use reduces the risk of breast cancer in Asian population. Herein, we retrospectively investigated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Breast Cancer
Main Authors: Lee, Jihyoun, Lee, Ji Sung, Lee, Jong Eun, Kim, Zisun, Han, Sun Wook, Hur, Sung Mo, Choi, Young Jin, Park, Sungmin
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Breast Cancer Society 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8250100/
https://ncbi.nlm.nih.gov/pubmed/34128366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2021.24.e28
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados